Laura Foll, Portfolio Manager of Lowland Investment Company, considers whether concerns about the outlook for the banking sector are overly pessimistic and explains why the Trust has increased its exposure to banks over the last 12 months.
Lorem ipsum dolor sit amet, cu mazim invidunt contentiones eam. Sea audire aperiam mentitum in, mea ei prima audire oporteat. No graecis delicatissimi mea, rebum nonumes eos ex. Sit vocibus facilis oportere et, ex facer causae aeterno est. Per quem euismod id, eos libris recusabo ad. Id quo antiopam suscipiantur, pri homero labores expetendis et.
Lorem ipsum dolor sit amet, cu mazim invidunt contentiones eam. Sea audire aperiam mentitum in, mea ei prima audire oporteat. No graecis delicatissimi mea, rebum nonumes eos ex. Sit vocibus facilis oportere et, ex facer causae aeterno est. Per quem euismod id, eos libris recusabo ad. Id quo antiopam suscipiantur, pri homero labores expetendis et.
Findings from a survey with Janus Henderson interns reveal an eagerness to learn about personal finance and investing.
Lorem ipsum dolor sit amet, cu mazim invidunt contentiones eam. Sea audire aperiam mentitum in, mea ei prima audire oporteat. No graecis delicatissimi mea, rebum nonumes eos ex. Sit vocibus facilis oportere et, ex facer causae aeterno est. Per quem euismod id, eos libris recusabo ad. Id quo antiopam suscipiantur, pri homero labores expetendis et.
The market’s optimistic assessment that inflation can easily be tamed is likely misplaced.
Why we believe the biopharma industry should be able to adapt to drug pricing changes.
Why we believe the biopharma industry should be able to adapt to drug pricing changes.
A turbulent year for both stocks and bonds may hold some silver linings.
A turbulent year for both stocks and bonds may hold some silver linings.